Boston Scientific Drops After Report of Pacemaker Battery Issues

Shares of Boston Scientific fell as much as 3.1% on Thursday after the New York Times reported that the Food and Drug Administration found issues with the firm’s pacemaker battery last spring.

• FDA inspectors found that a pacemaker battery made more recently had also failed, according to a report that has not previously been made public, the Times reported

To contact the reporter on this story:
Angel Adegbesan in New York at aadegbesan3@bloomberg.net

To contact the editors responsible for this story:
Matt Turner at mturner107@bloomberg.net

Ira Iosebashvili

© 2026 Bloomberg L.P. All rights reserved. Used with permission.